The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research......
Results from the first phase of the clinical trial of an Ebola vaccine based on the current strain of the virus suggests it is safe to use and provokes an immune response in recipients, Chinese......
A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found that it is safe and induces an immune response, a study published in The Lancet says. Scientists, including......
One Chinese lie has been finally nailed this time by a team of Indian scientists who provide irrefutable evidence that rice did originate in India, a fact contested by China. If one......
'If we play our cards right, we may even benefit from the competition between the US and China as seen from increased investment from each of these countries into India.''The size of our market......